Lonza TheraPEAK FGM-CD fibroblast growth medium

Friday, 22 July, 2011 | Supplied by: Lonza Australia Pty Ltd

TheraPEAK FGM-CD fibroblast growth medium - chemically defined and without phenol red and antibiotics - is designed to support the growth and proliferation of primary human dermal fibroblasts in culture.

The medium supports growth and proliferation of both adult and neonatal primary human dermal fibroblasts. Features include: maintains normal fibroblast characteristics comparable to serum-containing media; and supports growth of fibroblasts on tissue culture vessels from a variety of manufacturers with no requirement for pre-treatment with an attachment matrix.

The media is supplied in BulletKit format with basal medium and supplement for growth and proliferation. The media is suitable for further manufacturing or lab research use.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd